535 related articles for article (PubMed ID: 28460851)
21. Imaging features of
Chen Z; Zhao Y; Wang Q; Li Y; Li H; Zhou Y
Clin Rheumatol; 2022 May; 41(5):1499-1509. PubMed ID: 35088208
[TBL] [Abstract][Full Text] [Related]
22. Is PET/CT essential in the diagnosis and follow-up of temporal arteritis?
Salvarani C; Soriano A; Muratore F; Shoenfeld Y; Blockmans D
Autoimmun Rev; 2017 Nov; 16(11):1125-1130. PubMed ID: 28899801
[TBL] [Abstract][Full Text] [Related]
23. PET-CT findings in large vessel vasculitis presenting as FUO, a case report.
Akin E; Coen A; Momeni M
Clin Rheumatol; 2009 Jun; 28(6):737-8. PubMed ID: 19242771
[TBL] [Abstract][Full Text] [Related]
24. Extracranial giant cell arteritis: A narrative review.
Lensen KD; Voskuyl AE; Comans EF; van der Laken CJ; Smulders YM
Neth J Med; 2016 Jun; 74(5):182-92. PubMed ID: 27323671
[TBL] [Abstract][Full Text] [Related]
25. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries.
Brodmann M; Lipp RW; Passath A; Seinost G; Pabst E; Pilger E
Rheumatology (Oxford); 2004 Feb; 43(2):241-2. PubMed ID: 13130153
[TBL] [Abstract][Full Text] [Related]
26. [18F-FDG PET in the diagnosis of large vessel vasculitis].
Rehák Z; Fojtík Z; Stanícek J; Bolcák K; Frysáková L
Vnitr Lek; 2006 Nov; 52(11):1037-44. PubMed ID: 17165522
[TBL] [Abstract][Full Text] [Related]
27. [18F]FDG positron emission tomography and ultrasound in the diagnosis of giant cell arteritis: congruent or complementary imaging methods?
Imfeld S; Aschwanden M; Rottenburger C; Schegk E; Berger CT; Staub D; Daikeler T
Rheumatology (Oxford); 2020 Apr; 59(4):772-778. PubMed ID: 31436837
[TBL] [Abstract][Full Text] [Related]
28. The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis.
Berger CT; Sommer G; Aschwanden M; Staub D; Rottenburger C; Daikeler T
Swiss Med Wkly; 2018 Aug; 148():w14661. PubMed ID: 30141518
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of
Narváez J; Estrada P; Vidal-Montal P; Sánchez-Rodríguez I; Sabaté-Llobera A; Nolla JM; Cortés-Romera M
Arthritis Res Ther; 2024 Jan; 26(1):13. PubMed ID: 38172907
[TBL] [Abstract][Full Text] [Related]
30. Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study.
Vitiello G; Orsi Battaglini C; Carli G; Radice A; Matucci A; Vultaggio A; Olianti C; Parronchi P; Maggi E; Cammelli D
Angiology; 2018 Oct; 69(9):763-769. PubMed ID: 29343075
[TBL] [Abstract][Full Text] [Related]
31. Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT.
Henes JC; Mueller M; Pfannenberg C; Kanz L; Kötter I
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S43-8. PubMed ID: 21385544
[TBL] [Abstract][Full Text] [Related]
32. Cranial and large vessel activity on positron emission tomography scan at diagnosis and 6 months in giant cell arteritis.
Sammel AM; Hsiao E; Schembri G; Bailey E; Nguyen K; Brewer J; Schrieber L; Janssen B; Youssef P; Fraser CL; Laurent R
Int J Rheum Dis; 2020 Apr; 23(4):582-588. PubMed ID: 32100451
[TBL] [Abstract][Full Text] [Related]
33. [18F]FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis-lessons from a vasculitis clinic.
Imfeld S; Rottenburger C; Schegk E; Aschwanden M; Juengling F; Staub D; Recher M; Kyburz D; Berger CT; Daikeler T
Eur Heart J Cardiovasc Imaging; 2018 Aug; 19(8):933-940. PubMed ID: 29126277
[TBL] [Abstract][Full Text] [Related]
34. The value of ultrasound in diagnosing extracranial large-vessel vasculitis compared to FDG-PET/CT: A retrospective study.
Löffler C; Hoffend J; Benck U; Krämer BK; Bergner R
Clin Rheumatol; 2017 Sep; 36(9):2079-2086. PubMed ID: 28503707
[TBL] [Abstract][Full Text] [Related]
35. PET/CT in giant cell arteritis: High
Rehak Z; Vasina J; Ptacek J; Kazda T; Fojtik Z; Nemec P
Rev Esp Med Nucl Imagen Mol; 2016; 35(6):398-401. PubMed ID: 27177856
[No Abstract] [Full Text] [Related]
36. Imaging to predict early relapses after treatment discontinuation in patients with large vessel giant cell arteritis - A cohort study.
Hemmig AK; Rottenburger C; Baruti L; Mensch N; Aschwanden M; Kyburz D; Pradella M; Staub D; Stegert M; Berger CT; Imfeld S; Sommer G; Daikeler T
Semin Arthritis Rheum; 2024 Jun; 66():152425. PubMed ID: 38442463
[TBL] [Abstract][Full Text] [Related]
37. Distribution patterns of arterial affection and the influence of glucocorticoids on
Malich L; Gühne F; Hoffmann T; Malich A; Weise T; Oelzner P; Wolf G; Freesmeyer M; Pfeil A
RMD Open; 2022 Aug; 8(2):. PubMed ID: 35953239
[TBL] [Abstract][Full Text] [Related]
38. Clinically isolated aortitis: imaging features and clinical outcomes: comparison with giant cell arteritis and giant cell aortitis.
Aghayev A; Bay CP; Tedeschi S; Monach PA; Campia U; Gerhard-Herman M; Steigner ML; Mitchell RN; Docken WP; DiCarli M
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1433-1443. PubMed ID: 33128155
[TBL] [Abstract][Full Text] [Related]
39. Impact of previous glucocorticoid therapy on diagnostic accuracy of [18F] FDG PET-CT in giant cell arteritis.
Narváez J; Estrada P; Vidal-Montal P; Sánchez-Rodríguez I; Sabaté-Llobera A; Nolla JM; Cortés-Romera M
Semin Arthritis Rheum; 2023 Jun; 60():152183. PubMed ID: 36841055
[TBL] [Abstract][Full Text] [Related]
40. Patterns of extracranial involvement in newly diagnosed giant cell arteritis assessed by physical examination, colour coded duplex sonography and FDG-PET.
Förster S; Tato F; Weiss M; Czihal M; Rominger A; Bartenstein P; Hacker M; Hoffmann U
Vasa; 2011 May; 40(3):219-27. PubMed ID: 21638250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
